Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
CVS, Cigna and UnitedHealth
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of “engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs,
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit managers (PBMs), accusing them of engaging in practices that artificially inflated the list price of insulin drugs.
FTC Sues Drug Middlemen Over Manipulating Insulin Market
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
FTC sues CVS, Cigna, UnitedHealth over rising insulin prices
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years.
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
1d
Cigna Group stock outperforms competitors despite losses on the day
Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.
2d
Cigna scaling back Medicare Advantage footprint in 8 states next year
The reductions will affect roughly 5,400 members, mostly in Florida, according to a notice to marketing agents.
3d
Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
4d
on MSN
Cigna Demands FTC Retraction in Escalating Drug-Price Fight
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Modern Healthcare
3d
Cigna to cut Medicare Advantage plans in several states
Cigna is joining the chorus of health insurance companies detailing where they will scale back Medicare Advantage offerings ...
Fierce Healthcare
2d
Cigna trims Medicare Advantage plans in eight states
Cigna is reshaping its Medicare Advantage (MA) plan lineup across eight states, affecting members in 36 health plans. | Cigna ...
5d
Cigna Sues Federal Trade Commission Over ‘Defamatory’ Report
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
5d
on MSN
Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
United States
Express Scripts
insulin
Medicare Advantage
Federal Trade Commission
Feedback